Efficacy and safety of a triple active sore throat lozenge in the treatment of patients with acute pharyngitis: Results of a multi‐centre, randomised, placebo‐controlled, double‐blind, parallel‐group trial (DoriPha)

OBJECTIVE: The aim of this multi‐centre, randomised, double‐blind, placebo‐controlled trial was to compare the efficacy and safety of the fixed combination of 0.5 mg tyrothricin, 1.0 mg benzalkonium chloride, and 1.5 mg benzocaine (study drug marketed as Dorithricin(®)) in repeat dosing for 3 days t...

Descripción completa

Detalles Bibliográficos
Autores principales: Palm, Jürgen, Fuchs, Katharina, Stammer, Holger, Schumacher‐Stimpfl, Anne, Milde, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282512/
https://www.ncbi.nlm.nih.gov/pubmed/30329199
http://dx.doi.org/10.1111/ijcp.13272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282512/
https://www.ncbi.nlm.nih.gov/pubmed/30329199
http://dx.doi.org/10.1111/ijcp.13272

Ejemplares similares